EPS to Present at the 1st China Pharmaceutical Innovation Conference (CPIC 2026)
EPS experts will deliver two presentations at the 1st China Pharmaceutical Innovation Conference (CPIC 2026), to be held in Shanghai, China from July 22 to 24, 2026.
The presentations will address key considerations for companies exploring entry into the Japanese pharmaceutical market, including the attractiveness of the Japanese pharmaceutical market, recent changes in the clinical development environment, and regulatory and clinical development strategies. Another session will focus on the development of innovative Chinese pharmaceuticals in Japan, offering practical insights into the use of overseas data, strategies for including Japan into multi-regional clinical trials (MRCTs), collaboration with the Pharmaceuticals and Medical Devices Agency (PMDA), and the establishment of clinical trial implementation frameworks.
We look forward to welcoming participants to our sessions at the conference.
Date: July 22–24, 2026
Venue: National Exhibition and Convention Center (Shanghai)
URL: https://en.cpic-shanghai.com/
Presentation Schedule
July 24, 2026
Breaking Borders: Japan's Evolving Landscape for Global Innovators From Market Opportunity to Regulatory Strategy and Clinical Execution
Motoki Fujii
Practical Guidance for Initiating Clinical R&D of Chinese Innovative Drugs in Japan
Rokuya Nochi
Share this page